ClinicalTrials.gg
Drug

Darbepoetin alfa clinical trials

Also written Aranesp, Darbepoetin and BCD-066.

studies test it
125
open now
7
in phase 3
49
first study started
1999

How each study uses Darbepoetin alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Darbepoetin alfa studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Sept 2001 · ARANESP · BLA 103951 (FDA, Drugs@FDA)
European Union
8 Jun 2001 · Aranesp · EMEA/H/C/000332 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Darbepoetin alfa
88
Darbe
4
Aranesp (darbepoetin alfa)
2

Brand

Aranesp
41

Development codes

BCD-066
3
DA3880
1
Nesp
1
KRN321
1

Other names

Darbepoetin
8

Studies by the year they started

117 studies that test it; most in 2002 (20)

Studies that test Darbepoetin alfa, by start year
YearStudies
19992
20002
20012
200220
200312
200415
20057
200612
20073
20085
20094
20102
20112
20125
20131
20142
20152
20162
20175
20181
20192
20213
20221
20254
20261

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
51
Phase 3
49
Phase 4
17
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 74 · Other 51

Amgen (62) · Biocad (3) · Kyowa Kirin Co., Ltd. (3) · University of New Mexico (2) · M.D. Anderson Cancer Center (2) · Seoul National University Bundang Hospital (2) · University of Washington (2) · Institute of Liver and Biliary Sciences, India (2)

Often tested with

Tested in the same studies.

Pegfilgrastim (4) · Epoetin Alfa (4) · Roxadustat (2) · Canakinumab (1) · Filgrastim (1) · Paricalcitol (1) · R-CHOP Regimen (1) · Doxorubicin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Darbepoetin alfa is the comparator. A study of two new drugs counts under both.

  • 1GSK1278863 · Qilu Pharmaceutical Co., Ltd. · next primary completion May 2027
  • 1Efepoetin alfa · Genexine, Inc. · next primary completion Jun 2027
Reaching primary completion within a year · 4, 1 in phase 3

Studies that test Darbepoetin alfa, phase 3 first.

Studies

Open first, then newest update. How each study uses Darbepoetin alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 125

See all 125 studies that test Darbepoetin alfa →

Given beside what is tested · 7 — Darbepoetin alfa is usual care or a partner of the new treatment
As the comparator · 49 — what is tested is compared with Darbepoetin alfa

Showing 20 of 49.

Codes

What other systems call Darbepoetin alfa · ClinicalTrials.gg INT006503

  • MeSH (NLM) D000068256Darbepoetin alfaConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 15UQ94PT4PDARBEPOETIN ALFAConfirmed FDA, NLM, Wikidata
  • RxNorm 283838Confirmed FDA, Wikidata
  • Wikidata Q2178381darbepoetin alfaConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1878Darbepoetin AlfaOne source FDA
  • DrugBank DB00012One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.